Initiative for Vaccine Research (IVR) I8-MTG-0210 Immunization, Vaccines and Biologicals (IVB) World Health Organization 20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT TECHNICAL CONSULTATION ON MATERNAL INFLUENZA IMMUNIZATION EVIDENCE AND IMPLEMENTATION 25-26 MARCH 2015 SALLE D, WHO HQ, GENEVA, SWITZERLAND List of Participants Participants Alex Adjagba, SIVAC Initiative, AMP, France Bruna Alves de Rezende, SIVAC Initiative, AMP, France Azucena Bardaji, Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Spain Niranjan Bhat, PATH, Seattle, USA Zulfiqar Bhutta, (Co-chair) Centre for Global Child Health, Toronto, Canada Jan Bonhoeffer, Brighton Collaboration, Basel, Switzerland Joseph Bresee, US Centers for Disease Control and Prevention, Atlanta, USA Marta Coelho Nunes, Respiratory and Meningeal Pathogens Research Unit, Chris Hani-Baragwanath Hospital, Bertsham, Gauteng, South Africa Gaston De Serres, Institut National de Santé Publique du Québec, Québec, Canada Deshayne Fell, Born Ontario, Ottawa, Canada Jessica Fleming, PATH, Seattle, USA Brad Gessner, Agence de Médecine Préventive, Paris, France David Green, Public Health England, Centre for Infections, London, UK Sam Halabi, The O’Neill Institute for National and Global Health Law at Georgetown University, Washington DC, USA Alan Hinman, Taskforce for Global Health, Atlanta, USA Jane Hirst, Nuffield Department of Obstetrics & Gynaecology, University of Oxford, UK Angela Hwang, The Bill and Melinda Gates Foundation, Seattle, USA Terri Hyde , US Centers for Disease Control and Prevention, Atlanta, USA Mark Jit, Public Health England, London, UK Hope Johnson, GAVI Alliance, Geneva, Switzerland Judith Kallenberg, GAVI Alliance, Geneva, Switzerland Mark Katz, Independent Consultant, Tel Aviv, Israel Keith Klugman, The Bill and Melinda Gates Foundation, Seattle, USA Mark Loeb, McMaster University, Hamilton, Canada Helen Marshall, Robinson Research Institute, Adelaide, Australia Kim Mulholland, Royal Women's and Royal Children's Hospitals, Melbourne, Australia Kathleen Neuzil, Vaccine Access and Delivery (VAD) Program, PATH, Seattle, USA Katherine O’Brien, (Co-chair) International Vaccine Access Center, Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA Saad Omer, Emory University, Atlanta, USA Michael Pfleiderer, Viral Vaccines, Paul-Ehrlich-Institut, Langen, Germany Lois Privor-Dumm, Alliances and Information, The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA Helen Rees, Wits Reproductive Health and HIV Research Institute, University of Witwatersrand, Johannesburg, South Africa David Savitz, Brown University, Providence, USA Mark Steinhoff, University of Cincinnati, Cincinnati, USA Milagritos Tapia, University of Maryland, Baltimore, USA Sylvie van der Werf, Institut Pasteur, Paris, France Marcel Verweij, Wageningen University, Wageningen, Netherlands Alba Vilajeliu, GAVI Alliance, Geneva, Switzerland Yehia Wafa, Department of Obstetrics/Gynaecology, Al Azhar University, Cairo, Egypt Niteen Wairagkar, The Bill and Melinda Gates Foundation, Seattle, USA Mitchell Weiss, Swiss Tropical and Public Health Institute, Basel, Switzerland Unable to attend Karim Abawi, Geneva Foundation for Medical Eduction and Research, Geneva, Switzerland Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand Yirgu Gebrehiwot, Department of Obstetrics and Gynecology, Addis Ababa University, Medical Faculty, Addis Ababa, Ethiopia Stephen Hodgins, Save The Children, Westport, USA Anders Peter Hviid, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark Ruth Karron, International Health Johns Hopkins Bloomberg School of Public Health, Baltimore, USA Shabir Madhi, National Institute of Communicable Diseases, Johannesburg, South Africa Elizabeth Miller, Public Health England, London, UK Suellen Miller, Safe Motherhood Programs, Dept. Obstetrics, Gynecology & Reproductive Sciences, Bixby Center for Global Reproductive Health and Policy, University of California, USA Walter Orenstein, Emory University, Atlanta, USA 2 Janna Patterson, The Bill and Melinda Gates Foundation, Seattle, USA Chittaranjan Narahari Purandare, Indian College of Obstetricians and Gynaecologists, Mumbai, India Janell A. Routh, US Centers for Disease Control and Prevention, Atlanta, USA Dorothy Shaw, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA Claire-Ann Siegrist, Department of Pediatrics & Pathology- Immunology, Centre Médical Universitaire, Genève, Switzerland Ajoke Sobanjo-Ter Meulen, The Bill and Melinda Gates Foundation, Seattle, USA Carla Vizzotti, Ministry of Health and Social Affairs, Piso, Buenos Aires, Argentina Fredrick Were, Hurlingham Children's Clinic, University of Nairobi, Kenya Marc-Alain Widdowson, US Centers for Disease Control and Prevention, Atlanta, USA WHO Regional Offices Mable Carole Tevi Benissan, Routine Immunization and New Vaccines, WHO Regional Office for Africa, Brazzaville, Congo Pernille Jorgensen, Influenza and other Respiratory Pathogens, WHO Regional Office for Europe, Copenhagen, Denmark Alba Maria Ropero, Immunization, Pan American Health Organization, Washington, USA Suzanna Serruya, CLAP, Pan American Health Organization, Montevideo, Uruguay WHO Secretariat Paulus Bloem, Expanded Programme on Immunization Plus, Immunization, Vaccines and Biologicals Maurice Bucagu, Policy, Planning and Programmes, Maternal, Newborn, Child and Adolescent Health Thomas Cherian, Immunization, Vaccines and Biologicals Jan Hendriks, Public Health, Innovation and Intellectual Property Siddhivinayak Hirve, Hepatitis and PIP Framework, Pandemic and Epidemic Diseases Joachim Hombach, Initiative for Vaccine Research, Immunization, Vaccines and Biologicals Philipp Lambach, Initiative for Vaccine Research, Immunization, Vaccines and Biologicals Justin Ortiz, Initiative for Vaccine Research, Immunization, Vaccines and Biologicals Laszlo Palkonyay, Prequalification Team, Essential Medicines and Health Products Marc Gerard Perut, Initiative for Vaccine Research, Immunization, Vaccines and Biologicals Andreas Reis, Global Health Ethics, Knowledge, Ethics and Research Carmen Rodriguez Hernandez, Prequalification Team, Essential Medicines and Health Products Ozge Tuncalp Mingard, Maternal Perinatal Health, Prevent Unsafe Abortion, Reproductive Health and Research Ahmadu Yakubu, Immunization, Vaccines and Biologicals Patrick Zuber, Safety and Vigilance, Essential Medicines and Health Products 3 .